Analysed EVOMMUNE INC (EVMN:NYSE) News Sources
Evommune Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis
30-07-2026
yahoo.com
Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights
06-08-2026
yahoo.com
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis
08-09-2026
yahoo.com
Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
23-09-2026
yahoo.com
What is the current price of EVOMMUNE INC (EVMN:NYSE)?
The current price of EVOMMUNE INC (EVMN:NYSE) is $6.25.
EVOMMUNE INC (EVMN:NYSE) absolute price change since previous trading day?
The absolute price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is $-0.16.
EVOMMUNE INC (EVMN:NYSE) percentage price change since previous trading day?
The percentage price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is -2.4961%.
What is the most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE)?
The most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE) is 35 out of 100.
What is the most recent average sentiment for EVOMMUNE INC (EVMN:NYSE)?
The most recent sentiment for EVOMMUNE INC (EVMN:NYSE) is .
SEC-8K** Filing Available For EVOMMUNE INC (EVMN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.